This is a preview of subscription content, log in via an institution to check access.
Reference
Trifan A, et al. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older. Medicine 96: e9271, No. 50, Dec 2017. Available from: URL: http://doi.org/10.1097/MD.0000000000009271 - Romania
Rights and permissions
About this article
Cite this article
Antivirals. Reactions Weekly 1686, 49 (2018). https://doi.org/10.1007/s40278-018-41113-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-41113-x